cupric sulfate pentahydrate Report issue

Small molecule Approved FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem

Active Ingredient History

NOW
  • Now

Chemistry

  • SMILES: [Cu+2].[O-]S(=O)(=O)[O-]
  • InChIKey: ARUVKPQLZAKDPS-UHFFFAOYSA-L
  • Mol. Mass: 159.61
  • ALogP: Missing data
  • ChEMBL Molecule:
    cupric sulfate  
More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: No
  • Availability: Discontinued
  • Delivery Methods: Parenteral
  • Pro Drug: No

Alternative names

caustic powder | copper(2+) sulfate | copper(ii) sulphate | copper monosulfate | copper monosulphate | copper sulfate | copper sulfate (1:1) | copper sulfate pentahydrate | copper sulphate | cupric sulfate | cupric sulfate anhydrous | cupric sulfate, anhydrous | cupric sulfate pentahydrate | cupric sulphate anhydrous | cupric sulphate, anhydrous | e519

Organizations (4)

Research & Development (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (3)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (2)


 

Anemia

Anemia, Iron-Deficiency

Experimental Indications - Clinical Trial Phases 1-4 (0)

Overview

  • Highest Phase: N/A
  • # of Trials: 1
  • # of Trial Organizations: 1

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue